What is EOLS's gross margin?

Evolus (EOLS) has a gross margin of 65% and a net margin of -15%.

What is EOLS's P/E ratio?

Track Evolus (EOLS) P/E ratio, ROE, and valuation metrics over time.

Where can I see EOLS's full financials?

See Evolus (EOLS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Evolus (EOLS) Financials — Revenue, Earnings, Cash Flow

Also trades as: 0K16.L (LSE) · $vol 0M

$6.09

-0.36 (-5.58%)

Weekly Expected Move ±9.3%

$5 $6 $6 $7 $8

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 63 · $401.1M mcap · 50M float · 2.26% daily turnover · Short 28% of daily vol

📊 Key Metrics

TTM

$302M

Revenue

+9.6% YoY

$-43M

Net Income

+22.7% YoY

$-41M

Free Cash Flow

-43.0% YoY

64.8%

Gross Margin

-9.4%

Op. Margin

-14.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE493.9%

ROA-18.9%

ROIC-29.2%

Valuation

P/E-9.1

P/B-13.8

EV/EBITDA-26.3

Leverage

Debt/Equity-6.71

Current Ratio1.90

Interest Cov.-1.2x

Quality Scores

Piotroski F3/9

Altman Z-2.10

Beneish M-2.37